Market Cap
₹29,745 Cr.
P/E
40.17
About
Bayer CropScience Limited is the flagship company of the Bayer Group in India and is publicly listed on the Bombay Stock Exchange. The company is engaged in ‘Agri Care’ business which primarily includ… Read more
Bayer CropScience Limited is the flagship company of the Bayer Group in India and is publicly … Read more
Low
4381
52W Range
High
6977
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
25.99%
3yr Average
26.5%
5yr Average
23.46%
Net Profit Margin
Latest
14.51%
3yr Average
14.3%
5yr Average
13.52%
ROCE
Latest
16.57%
3yr Average
16.49%
5yr Average
17.09%
Debt to Equity
Latest
-
3yr Average
0.0
5yr Average
0.0
Market Share
20 %
(as of Mar 18)
Hybrid Seeds & RRFlex Segment Market Share
Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Asset Break-Up

Peer Comparison
Suppliers
  • Deepak Nitrite Ltd.
  • Aarti Industries Ltd.
  • Piramal Enterprises Ltd.
  • Navin Fluorine International Ltd.
  • Time Technoplast Ltd.
FAQs on Bayer CropScience Ltd. Business

Bayer CropScience Limited is a publicly listed company in India, specializing in the manufacture and distribution of agrochemical products and hybrid seeds.

Bayer CropScience major competitors are BASF India, Sumitomo Chemical India, UPL, Dhanuka Agritech, Rallis India, Sharda Cropchem, Bhagiradha Chem.
Market Cap of Bayer CropScience is ₹29,745 Crs.
While the median market cap of its peers are ₹7,727 Crs.

Bayer CropScience seems to be less financially stable compared to its peers.
Altman Z score of Bayer CropScience is 5.64 and is ranked 5 out of its 8 competitors.

Company Filing
2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Investor Presentation Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call Jun Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Jun Mar Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
Discussions & Analysis